Form 4: Haemonetics Director Diane M. Bryant Reports Acquisition of Restricted Stock Units

Director Diane M. Bryant reports acquisition of 2,207 restricted stock units (RSUs) of Haemonetics Corp.

Summary

• On July 25, 2024, Diane M. Bryant, a director of Haemonetics Corp, acquired 2,207 restricted stock units (RSUs).
• These RSUs were granted under the company's Amended and Restated 2019 Long-Term Incentive Compensation Plan.
• The RSUs vest 100% on the first anniversary of the grant date.
• Each RSU represents the right to receive one share of Haemonetics Corp's common stock upon vesting.
• Following the transaction, Ms. Bryant directly owns 4,433 shares of Haemonetics Corp common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider activity, which can be seen as a positive sign of alignment with shareholder interests, but doesn't provide strong positive or negative signals.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest 100% on the first anniversary of the grant date, indicating a future event where shares will be issued.

Industry Context

This is a standard Form 4 filing, reflecting insider transactions in accordance with SEC regulations. It is common for companies to grant stock options and restricted stock units to directors and employees as part of their compensation packages.

Stakeholder Impact

• The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.

Next Steps

• The RSUs will vest on the first anniversary of the grant date, at which point the director will receive shares of Haemonetics Corp common stock.

Key Dates